Cytokine and Humoral Immune Responses to a Goatpox Vaccine in Mithun (Bos frontalis): A Year-Long Field Investigation - Takeaways - MDSpire

Cytokine and Humoral Immune Responses to a Goatpox Vaccine in Mithun (Bos frontalis): A Year-Long Field Investigation

  • By

  • Gundallahalli Bayyappa Manjunatha Reddy

  • Vikram Ramesh

  • Yallappa M. Somagond

  • Plabita Goswami

  • Selvaraj Ragulraj

  • Hlawndo Lalzampuia

  • Suchismitha Pal

  • Sudeep Nagaraj

  • Sunil Tadakod

  • Uzma Jabeen

  • Shraddha Bijalwan

  • Muthannan Andavar Ramakrishnan

  • Baldev Raj Gulati

  • Patil Shivanagowda Girish

  • April 21, 2026

  • 0 min

Share

  • 1

    A year-long study assessed the immune response to a goatpox vaccine in seronegative Mithun, addressing Lumpy Skin Disease (LSD) concerns in Northeast India.

  • 2

    The goatpox vaccine was found safe, with no adverse reactions or viral shedding detected in Mithun during the 12-month observation period.

  • 3

    Significant seroconversion and cytokine upregulation occurred post-vaccination, peaking at 30 days, indicating a robust immune response.

  • 4

    Spatial mapping revealed ongoing LSDV activity in Mithun populations, highlighting the need for effective vaccination strategies.

  • 5

    This study provides essential baseline data for future evaluations of LSD control measures in Mithun, a vulnerable bovine species.

Original Source(s)

Related Content